tupungato
Tevogen Bio (NASDAQ:TVGN) stock jumped nearly 30% post-market after the company announced it has expanded its relationship with Microsoft (NASDAQ:MSFT) to broaden their AI-focused collaboration and build its PredicTcell technology for predictive precision T cell targeting.
The Tevogen.AI initiative will